Table 1.
HPV genotypes in patients with low-grade cervical lesions
Number of patients | Diagnosis | Age | HPV Infection | Patient’s number | Diagnosis | Age | HPV infection | ||
---|---|---|---|---|---|---|---|---|---|
Low risk | High risk | Low risk | High risk | ||||||
1 | HPV-I | 29 | 18 | 35 | HPV-I | 48 | nd | ||
2 | HPV-I | 34 | nd | 36 | HPV-I | 53 | nd | ||
3 | HPV-I | 23 | nd | 37 | HPV-I | 44 | nd | ||
4 | HPV-I | 24 | 6, 11 | 18 | 38 | CIN-I | 29 | 18 | |
5 | HPV-I | 35 | 18 | 39 | CIN-I | 25 | 18 | ||
6 | HPV-I | 29 | 18 | 40 | CIN-I | 29 | 18 | ||
7 | HPV-I | 24 | 18 | 41 | CIN-I | 26 | 18 | ||
8 | HPV-I | 22 | 18 | 42 | CIN-I | 40 | nd | ||
9 | HPV-I | 32 | 18 | 43 | CIN-I | 35 | 18 | ||
10 | HPV-I | 21 | 18 | 44 | CIN-I | 27 | 18 | ||
11 | HPV-I | 23 | 18 | 45 | CIN-I | 24 | 18 | ||
12 | HPV-I | 35 | 18 | 46 | CIN-I | 25 | 6, 11 | 18 | |
13 | HPV-I | 39 | 18 | 47 | CIN-I | 26 | nd | ||
14 | HPV-I | 34 | 18 | 48 | CIN-I | 22 | nd | ||
15 | HPV-I | 26 | 16,18 | 49 | CIN-I | 27 | 6, 11 | 18 | |
16 | HPV-I | 23 | 18 | 50 | CIN-I | 29 | nd | ||
17 | HPV-I | 38 | nd | 51 | CIN-I | 37 | 6, 11 | 18 | |
18 | HPV-I | 27 | nd | 52 | CIN-I | 35 | 18 | ||
19 | HPV-I | 34 | 18 | 53 | CIN-I | 31 | 18 | ||
20 | HPV-I | 26 | nd | 54 | CIN-I | 31 | 18 | ||
21 | HPV-I | 28 | 18 | 55 | CIN-I | 39 | 18 | ||
22 | HPV-I | 40 | 18 | 56 | CIN-I | 21 | Negative | ||
23 | HPV-I | 24 | 18 | 57 | CIN-I | 28 | 18 | ||
24 | HPV-I | 25 | 6, 11 | 18 | 58 | CIN-I | 35 | nd | |
25 | HPV-I | 19 | 6, 11 | 18 | 59 | CIN-I | 40 | nd | |
26 | HPV-I | 36 | 18 | 60 | CIN-I | 38 | nd | ||
27 | HPV-I | 20 | nd | 61 | CIN-I | 33 | Nd | ||
28 | HPV-I | 21 | nd | 62 | CIN-I | 41 | Nd | ||
29 | HPV-I | 24 | nd | 63 | CIN-I | 41 | 16,18 | ||
30 | HPV-I | 45 | 18 | 64 | CIN-I | 55 | Negative | ||
31 | HPV-I | 44 | 18 | 65 | CIN-I | 45 | 18 | ||
32 | HPV-I | 44 | nd | 66 | CIN-I | 43 | 18 | ||
33 | HPV-I | 45 | Negative | 67 | CIN-I | 55 | 6, 1.1 | 18 | |
34 | HPV-I | 60 | nd | 68 | CIN-I | 41 | Nd |
HPV = Human papillomavirus; nd = not determined.